Published online December 31, 2007
PEDIATRICS Vol. 121 No. 1 January 2008, pp. 97-105 (doi:10.1542/peds.2007-0644)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Slidsborg, C.
Right arrow Articles by la Cour, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Slidsborg, C.
Right arrow Articles by la Cour, M.
Related Collections
Right arrow Ophthalmology

ARTICLE

Treatment for Retinopathy of Prematurity in Denmark in a Ten-Year Period (1996–2005): Is the Incidence Increasing?

Carina Slidsborg, MDa, Henrik Bom Olesen, MDa, Peter Koch Jensen, MDa, Hanne Jensen, MD, DrMedScib, Kamilla Rothe Nissen, MD, PhDa, Gorm Greisen, MDc, Steen Rasmussen, MScd, Hans Callø Fledelius, MD, DrMedScia and Morten la Cour, MD, DrMedScia,b

a Departments of Ophthalmology
c Neonatology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
b Department of Ophthalmology, Copenhagen University Hospital, Glostrup Hospital, Copenhagen, Denmark
d National Board of Health, Copenhagen, Denmark

OBJECTIVE. The objective of this study was to analyze the population incidence of retinopathy of prematurity treatment in Denmark in the 10-year period from 1996 to 2005.

METHODS. Patient charts of infants treated for retinopathy of prematurity and the national birth registry provide information about neonatal parameters. These parameters, along with birth in the latter half of the period (2001–2005), were analyzed as risk factors for retinopathy of prematurity. The national registry for blind and visually impaired children was accessed to obtain information about visual impairment attributable to retinopathy of prematurity in both treated and untreated infants.

RESULTS. The study population consisted of 5467 Danish preterm infants born in 1996 to 2005, with a gestational age of <32 weeks, who survived for ≥5 postnatal weeks; 2616 were born in 1996 to 2000, and 2851 were born in 2001 to 2005. The incidence of treated retinopathy of prematurity cases increased significantly from 1.3% in 1996 to 2000 to 3.5% in 2001 to 2005. Significant risk factors for retinopathy of prematurity treatment were low gestational age, small for gestational age, male gender, and multiple birth. Other, yet unknown factors contributed to the increased incidence in the latter half of the period. Of the study population, 0.6% were registered as visually impaired because of retinopathy of prematurity within 2 years after birth (early-detected visual impairment). The incidences were not significantly different between 1996 to 2000 and 2001 to 2005. Of all of the early-detected, visually impaired children, 16% had not been treated for retinopathy of prematurity and were considered screening failures.

CONCLUSIONS. The incidence of retinopathy of prematurity treatment in Denmark has more than doubled during the past half-decade. This increase could not be fully explained by increased survival rates for the infants or by changes in the investigated neonatal risk factors.


Key Words: incidence • preterm delivery • retinopathy of prematurity • retinal ablation therapy • low gestational age • low birth weight • small for gestational age • gender • multiple birth

Abbreviations: ROP—retinopathy of prematurity • GA—gestational age • BW—birth weight • NBR—national birth registry • NRBVIC—national registry for blind and visually impaired children • PNA—postnatal age • SGA—small for gestational age • T-ROP—threshold retinopathy of prematurity


Accepted Jun 20, 2007.